Table 2.
Results of the study's parameters
| VARIABLE | GROUP | Mean | S.D. | p-value |
|---|---|---|---|---|
| Soluble ST2 (ng/ml) | A | 9,16 | 4,56 | <0,001 |
| B | 9,93 | 3,57 | ||
| C | 11,31 | 3,05 | ||
| D | 14,97 | 5,23 | ||
| BNP (pg/ml) | A | 28,78 | 13,73 | 0,301 |
| B | 33,37 | 19,88 | ||
| C | 40,06 | 31,39 | ||
| D | 29,63 | 22,55 | ||
|
hs-CRP (mg/lt) |
A | 3,04 | 4,45 | 0,039 |
| B | 3,34 | 4,87 | ||
| C | 5,61 | 6,21 | ||
| D | 6,35 | 5,79 | ||
|
Fibrinogen (gr/lt) |
A | 4,00 | 0,81 | 0,302 |
| B | 3,84 | 0,60 | ||
| C | 4,35 | 1,55 | ||
| D | 3,82 | 1,21 | ||
|
Fasting Plasma Glucose (mg/dl) |
A | 94,71 | 10,24 | <0,001 |
| B | 100,00 | 11,48 | ||
| C | 137,75 | 37,59 | ||
| D | 136,54 | 30,05 | ||
|
eGFR (mlt/min) |
A | 106,70 | 27,05 | 0,393 |
| B | 107,44 | 27,90 | ||
| C | 120,58 | 44,68 | ||
| D | 124,50 | 43,61 | ||
| Total Cholesterol (mg/dl) | A | 211,57 | 34,83 | <0,001 |
| B | 222,00 | 44,74 | ||
| C | 208,88 | 44,95 | ||
| D | 173,64 | 39,03 | ||
|
HDL (mg/dl) |
A | 51,24 | 11,67 | <0,001 |
| B | 49,33 | 14,42 | ||
| C | 47,25 | 15,97 | ||
| D | 39,60 | 9,96 | ||
|
LDL (mg/dl) |
A | 136,83 | 30,12 | <0,001 |
| B | 143,84 | 36,66 | ||
| C | 137,13 | 37,22 | ||
| D | 101,22 | 36,66 | ||
| Triglycerides (mg/dl) | A | 116,52 | 43,80 | 0,002 |
| B | 148,56 | 47,83 | ||
| C | 124,25 | 52,77 | ||
| D | 159,30 | 73,90 | ||
|
HbA1c (%) |
A | 6,08 | 0,36 | <0,001 |
| B | 6,46 | 0,38 | ||
| C | 8,67 | 2,08 | ||
| D | 7,92 | 1,21 | ||
We used the Kruskal-Wallis test to analyze the variability of the continuous variables of the study. Significant variability among the 4 study groups was noted for the mean values of sST2, hs-CRP, FPG, total Cholesterol, HDL, LDL, Triglycerides and HbA1c. No variability was found for the mean values of BNP, fibrinogen and eGFR.